Clinical Trial Update: A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updating the study of CS3007 in patients with gastrointestinal stromal tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• CS3007

Snippet

Sponsor: CStone Pharmaceuticals | Conditions: Gastrointestinal Stromal Tumors | Phase 1, Phase 2 | Status: COMPLETED